24 November 2017
News and Views
Links and Services
A study in September's issue of the Alimentary Pharmacology & Therapeutics examines alpha anti-tumor necrosis factor treatment of IBD in liver transplant recipients.
Ulcerative colitis and Crohn's disease can sometimes relapse and be refractory to standard treatm
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors